# Capital Bancorp Inc: overview CBNK · Nasdaq · CIK 1419536 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cbnk.md) · [Financials](/companies/cbnk/financials.md) · [Filings](/companies/cbnk/filings.md) · [Insiders](/companies/cbnk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.62](/filings/0001419536-25-000111.md) | not reported | [0.82](/filings/0001419536-26-000100.md) | [0.78](/filings/0001419536-26-000112.md) | [0.89](/filings/0001419536-25-000111.md) | not reported | [0.73](/filings/0001419536-26-000100.md) | [0.87](/filings/0001419536-26-000112.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.84](/filings/0001419536-23-000054.md) | [2.91](/filings/0001628280-24-011467.md) | [2.55](/filings/0001419536-25-000047.md) | [2.12](/filings/0001419536-26-000073.md) | [3.41](/filings/0001419536-26-000073.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cbnk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $27.6m | 786,588 | | Added +64,576 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.5m | 497,906 | | Added +1,157 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $13.8m | 392,750 | | Added +37,284 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $13.1m | 439,426 | | Reduced −67,564 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.5m | 298,500 | | Added +15,753 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $10.4m | 295,949 | | Added +92,753 | | [Wealthspire Advisors, LLC](/funds/1646247.md) | 2026-06-30 | $10.2m | 291,615 | | Reduced −3,802 | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $10.1m | 286,371 | | Added +55,085 | | [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $9.3m | 264,465 | | Reduced −4,851 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.4m | 239,814 | | Added +7,227 | ## Recent filings [All 714 filings](/companies/cbnk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 16:04 ET | [8-K](/filings/0001419536-26-000166.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001419536-26-000166 | | 2026-09-30 | 08:59 ET | [8-K](/filings/0001419536-26-000148.md) | 8.01 Other events | 0001419536-26-000148 | | 2026-09-30 | 07:03 ET | [8-K](/filings/0001419536-26-000145.md) | 1.01 Entry into a material agreement | 0001419536-26-000145 | | 2026-08-14 | 16:01 ET | [8-K](/filings/0001419536-26-000114.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001419536-26-000114 | | 2026-08-07 | 15:21 ET | [10-Q](/filings/0001419536-26-000112.md) | Quarterly report, period 2026-06-30 | 0001419536-26-000112 | | 2026-07-27 | 16:05 ET | [8-K](/filings/0001419536-26-000109.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001419536-26-000109 | | 2026-06-17 | 16:05 ET | [8-K](/filings/0001419536-26-000105.md) | 7.01 Regulation FD disclosure | 0001419536-26-000105 | | 2026-06-01 | 16:05 ET | [8-K](/filings/0001419536-26-000103.md) | 5.07 Shareholder vote results | 0001419536-26-000103 | | 2026-05-08 | 16:11 ET | [10-Q](/filings/0001419536-26-000100.md) | Quarterly report, period 2026-03-31 | 0001419536-26-000100 | | 2026-04-27 | 16:10 ET | [8-K](/filings/0001419536-26-000097.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001419536-26-000097 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001419536-26-000073.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1419536 - Tickers: CBNK - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: MD - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 09:03 ET. No prices; not investment advice.